20240018163. NEW THIAZOLOPYRIMIDINONE DERIVATIVES simplified abstract (Hoffmann-La Roche Inc.)

NEW THIAZOLOPYRIMIDINONE DERIVATIVES

Organization Name

Hoffmann-La Roche Inc.

Inventor(s)

Virginie Brom of Blotzheim (FR)

Cosimo Dolente of Allschwil (CH)

Delphine Gaufreteau of Kembs (FR)

Nadine Grether of Moehlin (CH)

Fionn Susannah O'hara of Basel (CH)

Matilde Piras of Basel (CH)

Hasane Ratni of Habsheim (FR)

Michael Reutlinger of Freiburg (DE)

Walter Vifian of Sissach (CH)

Claudio Zambaldo of Basel (CH)

NEW THIAZOLOPYRIMIDINONE DERIVATIVES - A simplified explanation of the abstract

This abstract first appeared for US patent application 20240018163 titled 'NEW THIAZOLOPYRIMIDINONE DERIVATIVES

Simplified Explanation

The abstract of the patent application states that a compound of formula (i) can be used as a medicament.

• The compound of formula (i) has potential applications as a medicament.
• The patent application describes the compound and its use as a medicament.
• The compound is defined in the description and claims of the patent application.
• The abstract does not provide specific details about the compound or its properties.
• The abstract does not oversell the compound or its potential benefits.

Potential Applications:

• The compound of formula (i) can be used as a medicament.
• It may have therapeutic applications in treating specific diseases or conditions.

Problems Solved:

• The compound may address specific medical problems or conditions.
• The patent application does not provide specific details about the problems solved.

Benefits:

• The compound may offer therapeutic benefits in the field of medicine.
• It may provide a new treatment option for certain diseases or conditions.

Original Abstract Submitted

wherein r—rand a-aare as defined in the description and in the claims. the compound of formula (i) can be used as a medicament.